Hydroxyapatite coatings for metallic implants

Hydroxyapatite (HAp) for Biomedical Applications

Volumn , Issue , 2015, Pages 143-157

  Bose, S ^a   Tarafder, S ^a   Bandyopadhyay, A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Bonding zone; Bone tissue; Calcium phosphates; Coating; Coating processes; Coating requirements; Hydroxyapatite; Hydroxycarbonate apatite; Orthopedic application

Indexed keywords

BIOMECHANICS; BONE; CALCIUM; CALCIUM PHOSPHATE; HYDROXYAPATITE; PHOSPHATE COATINGS; PHOSPHATE MINERALS; TISSUE;

BONDING ZONE; BONE TISSUE; COATING PROCESS; HYDROXY-CARBONATE-APATITE; ORTHOPEDIC APPLICATIONS;

COATINGS;

EID: 84940094629     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978178242033000007-9     Document Type: Chapter

References (50)

1. American Academy Of Orthopedic Surgeons (AAOS). http://orthoinfo.aaos.org.
2. 2 dopants. J. Am. Ceram. Soc. 2006, 89:2675-2688.
3. Banerjee A., Bandyopadhyay A., Bose S. Hydroxyapatite nanopowders: synthesis, densification and cell-materials interaction. Mater. Sci. Eng. C 2007, 27:729-735.
4. Bauer T.W., Taylor S.K., Jiang M., Medendorp S.V. An indirect comparison of third-body wear in retrieved hydroxyapatite-coated, porous, and cemented femoral components. Clin. Orthop. 1994, 298:11-18.
5. Becker S.T., Warnke P.H., Behrens E., Wiltfang J. Morbidity after iliac crest bone graft harvesting over an anterior versus posterior approach. J. Oral Maxillofac. Surg. 2011, 69:48-53.
6. Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cementsortofosfatos de calcio en medicina: de la cerámica a los cementos de fosfato de calcio. Injury 2000, 31:D37-D47.
7. Bone and Joint Action Week. http://www.usbji.org/programs/public-education-programs/action-week.
8. Bone and Joint Initiative (USBJI). http://www.usbji.org.
9. Bose S., Saha S.K. Synthesis and characterization of hydroxyapatite nanopowders by emulsion technique. Chem. Mater. 2003, 15:4464-4469.
10. Brown T.E., Harper B.L., Bjorgul K. Comparison of cemented and uncemented fixation in total knee arthroplasty. Orthopedics 2013, 36:380-387.
11. Callahan T., Gantenberg J., Sands B. Calcium Phosphate (Ca-P) Coating Draft Guidance for Preparation of Food and Drug Administration (FDA) Submissions for Orthopedic and Dental Endosseous Implants. Characterization and Performance of Calcium Phosphate Coatings for Implants 1994, 185-198. ASTM International, West Conshohocken, PA. E. Horowitz, J. Parr (Eds.).
12. Centers for Disease Control and Prevention (CDC). http://www.cdc.gov.
13. Dalton J.E., Cook S.D. In vivo mechanical and histological characteristics of HA-coated implants vary with coating vendor. J. Biomed. Mater. Res. 1995, 29:239-245.
14. D'Antonio J.A., Capello W.N., Crothers O.D., Jaffe W.L., Manley M.T. Early clinical experience with hydroxyapatite-coated femoral implants. J. Bone Joint Surg. 1992, 74:995-1008.
15. De Groot K., Geesink R., Klein C.P., Serekian P. Plasma sprayed coatings of hydroxylapatite. J. Biomed. Mater. Res. 1987, 21:1375-1381.
16. Donor Site Morbidity After Anterior Iliac Crest Bone Harvest: Spine n.d.
17. Dorr L.D., Wan Z., Song M., Ranawat A. Bilateral total hip arthroplasty comparing hydroxyapatite coating to porous-coated fixation. J. Arthroplasty 1998, 13:729-736.
18. Furlong R.J., Osborn J.F. Fixation of hip prostheses by hydroxyapatite ceramic coatings. J. Bone Joint Surg. Br. 1991, 73-B:741-745.
19. Geesink R.G., Hoefnagels N.H. Six-year results of hydroxyapatite-coated total hip replacement. J. Bone Joint Surg. Br. 1995, 77-B:534-547.
20. Glant T., Jacobs J., Mikecz K., Yao J., Chubinskaja S., Williams J., et al. Particulate-induced, prostaglandin and cytokine-mediated bone resorption in an experimental system and in failed joint replacements. Am. J. Ther. 1996, 3.
21. Gross R.H. The use of bone grafts and bone graft substitutes in pediatric orthopaedics. J. Pediatr. Orthop. 2012, 32:100-105.
22. Habibovic P., Barrère F., Van Blitterswijk C.A., de Groot K., Layrolle P. Biomimetic hydroxyapatite coating on metal implants. J. Am. Ceram. Soc. 2002, 85:517-522.
23. Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004. Arthritis Rheum. 2008, 59:481-488.
24. Kim Y.-H., Kim J.-S., Oh S.-H., Kim J.-M. Comparison of porous-coated titanium femoral stems with and without hydroxyapatite coating. J. Bone Joint Surg. 2003, 85:1682-1688.
25. Kneser U., Schaefer D.J., Polykandriotis E., Horch R.E. Tissue engineering of bone: the reconstructive surgeon's point of view. J. Cell. Mol. Med. 2006, 10:7-19.
26. Kolk A., Handschel J., Drescher W., Rothamel D., Kloss F., Blessmann M., et al. Current trends and future perspectives of bone substitute materials-from space holders to innovative biomaterials. J. CranioMaxillofac. Surg. 2012, 40:706-718.
27. Krishna B.V., Xue W., Bose S., Bandyopadhyay A. Engineered porous metals for implants. JOM 2008, 60:45-48.
28. Kurtz S., Ong K., Lau E., Mowat F., Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. 2007, 89:780-785.
29. Lacefield W.R. Hydroxyapatite coatings. Ann. N. Y. Acad. Sci. 1988, 523:72-80.
30. Lai C., Tang S., Wang Y., Wei K. Formation of calcium phosphate nanoparticles in reverse microemulsions. Mater. Lett. 2005, 59:210-214.
31. Maitra A. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy. Expert Rev. Mol. Diagn. 2005, 5:893-905.
32. Mavis B., Taş A.C. Dip coating of calcium hydroxyapatite on Ti-6Al-4V substrates. J. Am. Ceram. Soc. 2000, 83:989-991.
33. McNally S.A., Shepperd J.A.N., Mann C.V., Walczak J.P. The results at nine to twelve years of the use of a hydroxyapatite-coated femoral stem. J. Bone Joint Surg. Br. 2000, 82-B:378-382.
34. Moroni A., Faldini C., Marchetti S., Manca M., Consoli V., Giannini S. Improvement of the bone-pin interface strength in osteoporotic bone with use of hydroxyapatite-coated tapered external-fixation pins. J. Bone Joint Surg. 2001, 83:717-721.
35. Narayanan R., Seshadri S.K., Kwon T.Y., Kim K.H. Calcium phosphate-based coatings on titanium and its alloys. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 85B:279-299.
36. National Osteoporosis Foundation. http://www.nof.org.
37. Palmer L.C., Newcomb C.J., Kaltz S.R., Spoerke E.D., Stupp S.I. Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel. Chem. Rev. 2008, 108:4754-4783.
38. Rey C. Calcium phosphate biomaterials and bone mineral. Differences in composition, structures and properties. Biomaterials 1990, 11:13-15.
39. Røkkum M., Reigstad A., Johansson C.B. HA particles can be released from well-fixed HA-coated stems. Acta Orthop. 2002, 73:298-306.
40. Rorabeck C.H. Tapered hydroxyapatite-coated press-fit stems: any added value?. J. Arthroplasty 2006, 21:85-88.
41. Roy I., Mitra S., Maitra A., Mozumdar S. Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int. J. Pharm. 2003, 250:25-33.
42. Roy M., Bandyopadhyay A., Bose S. Induction plasma sprayed Sr and Mg doped nano hydroxyapatite coatings on Ti for bone implant. J. Biomed. Mater. Res. B Appl. Biomater. 2011, 99B:258-265.
43. Roy M., Bandyopadhyay A., Bose S. Induction plasma sprayed nano hydroxyapatite coatings on titanium for orthopaedic and dental implants. Surf. Coat. Technol. 2011, 205:2785-2792.
44. Søballe K., Overgaard S. The current status of hydroxyapatite coating of prostheses. J. Bone Joint Surg. Br. 1996, 78-B:689-691.
45. Sáenz A., Rivera E., Brostow W., Castano V.M. Ceramic biomaterials: an introductory overview. J. Mater. Educ. 1999, 21:267-276.
46. Sun L., Berndt C.C., Gross K.A., Kucuk A. Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: a review. J. Biomed. Mater. Res. 2001, 58:570-592.
47. Surmenev R.A. A review of plasma-assisted methods for calcium phosphate-based coatings fabrication. Surf. Coat. Technol. 2012, 206:2035-2056.
48. The Use of Hydroxyapatite on Press-fit Tapered Femoral Stems | Orthopedics n.d.
49. Wechter J., Comfort T.K., Tatman P., Mehle S., Gioe T.J. Improved survival of uncemented versus cemented femoral stems in patients aged < 70 years in a community total joint registry. Clin. Orthop. Relat. Res. 2013, 471:3588-3595.
50. Zimmermann G., Moghaddam A. Allograft bone matrix versus synthetic bone graft substitutes. Injury 2011, 42(Suppl. 2):S16-S21.